ARA-290, also known as cibinetide, is an 11-amino-acid peptide derived from erythropoietin. The page describes it as a peptide therapy studied for tissue-protective, anti-inflammatory, and neurorestorative effects without stimulating red blood cell production like erythropoietin.

How does ARA-290 work?

The page explains that ARA-290 works by activating the body’s natural repair system, particularly during nerve injury, inflammation, poor metabolic health, or low oxygen states. It is presented as supporting repair pathways rather than simply masking symptoms.

Does ARA-290 help with neuropathy?

The page states that research has explored ARA-290 for improving neuropathic symptoms by supporting nerve repair and reducing inflammation, particularly in settings involving small fiber nerve damage and nerve discomfort.

How long does it take to see results from ARA-290?

The page notes that response time can vary by patient, but some individuals may notice improvement in nerve symptoms or discomfort within weeks when used as part of a physician-guided protocol.

The page describes ARA-290 as having a favorable safety profile in studies, while emphasizing that peptide therapy should be reviewed by a qualified physician to determine suitability based on medical history, medications, and overall treatment goals.

How is ARA-290 administered?

The page states that ARA-290 is commonly administered by subcutaneous injection as part of a physician-guided peptide therapy protocol.

ARA-290 Peptide Therapy

Q: What is ARA-290 used for?

The page discusses ARA-290 in the context of neuropathy, nerve repair, neuroinflammation, and recovery from injury or metabolic stress, with use determined by physician guidance and individual treatment goals.

Neurorestorative & Nerve Repair Support

ARA-290 is a peptide derived from erythropoietin that is currently being studied for its ability to support nerve repair, reduce inflammation, and improve neuropathy symptoms. It is commonly used in advanced peptide protocols focused on neurorecovery, tissue repair, and longevity optimization.

ARA-290 is designed to activate repair pathways without increasing red blood cell production, making it a targeted option for patients seeking recovery-focused therapies.

What is ARA-290?

ARA-290 (also known as cibinetide) is an 11-amino-acid peptide engineered from erythropoietin. It activates the body’s innate repair receptor, which plays a key role in:

Tissue repair
Inflammation control
Nerve regeneration
Cellular protection

This makes ARA-290 a unique peptide for patients dealing with neuropathy, nerve damage, or chronic inflammation.

How ARA-290 Works

ARA-290 helps your body turn on its built-in repair system—especially when it’s dealing with nerve damage, inflammation, poor metabolic health, or low oxygen. Instead of masking symptoms, ARA-290 may help the body restore normal healing processes.

This mechanism is why ARA-290 peptide therapy is commonly used for:

Peripheral neuropathy
Small fiber neuropathy
Nerve pain and tingling
Post-injury nerve recovery
Neuroinflammation

By improving the repair environment, ARA-290 may help patients experience long-term improvement rather than temporary symptom relief.

Benefits of ARA-290 Peptide Therapy

Supports Nerve Repair

ARA-290 may help stimulate pathways involved in nerve regeneration and recovery, particularly in patients with neuropathy.

Reduces Neuropathic Pain

Clinical research has explored its role in improving symptoms such as burning, tingling, and nerve discomfort.

Targets Inflammation at the Source

ARA-290 may help regulate inflammatory signaling linked to chronic disease and nerve damage.

No Increase in Red Blood Cells

Unlike erythropoietin, ARA-290 does not significantly raise hematocrit, making it a safer option for long-term use under physician supervision.

Supports Brain and Nervous System Health

It has been studied for both peripheral nerve repair and central nervous system support, making it valuable in neurorecovery protocols.

Who is ARA-290 For?

ARA-290 peptide therapy may be appropriate for individuals experiencing:

Neuropathy (diabetic or idiopathic)
Nerve pain or nerve damage
Chronic inflammation
Poor recovery from injury
Neuroinflammatory conditions

A physician evaluation is required to determine if ARA-290 fits your personalized treatment plan.

ARA-290 FAQ

What is ARA-290 used for?

ARA-290 is commonly used in peptide therapy protocols for neuropathy, nerve repair, and inflammation-related conditions.

Does ARA-290 help neuropathy?

Research suggests ARA-290 may improve symptoms of neuropathy by supporting nerve regeneration and reducing inflammation.

How does ARA-290 differ from erythropoietin?

ARA-290 is made from erythropoietin but does not stimulate red blood cell production, it focuses more on repair and protection pathways.

How long does ARA-290 take to work?

Response time varies, but some patients report improvements in nerve symptoms and pain within weeks under physician-guided therapy.

Is ARA-290 safe?

Studies show a favorable safety profile, but treatment should always be managed by a qualified physician.

Can ARA-290 cross the blood-brain barrier?

ARA-290 is commonly discussed as having central nervous system activity, contributing to its use in neurorecovery protocols.

Where can I get ARA-290 therapy?

ARA-290 is a prescription that is filled through our US licensed compounding pharmacy and shipped to you.

Consultation for ARA-290 Peptide Therapy

If you are interested in ARA-290 for neuropathy, nerve repair, or inflammation support, schedule a consultation with Transformyou.

Our physician will evaluate:

Your symptoms and goals
Medical history
Current medications
Whether ARA-290 is appropriate for your plan

Research

Brines M, et al. ARA 290 improves metabolic control and neuropathic symptoms in type 2 diabetes. Molecular Medicine.

Swartjes M, et al. ARA-290 produces long-term relief of neuropathic pain in experimental models.Anesthesiology.

Dahan A, et al. Targeting the innate repair receptor to treat neuropathy. Pain Reports.

Collino M, et al. Innate protection and repair signaling via erythropoietin-derived peptides. Pharmacology & Therapeutics.